Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barone

Showing results (351-360 of 399) with videos related to

Pageof 40
Sort By:
Circulation Research|June 1, 1997
Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injuryX L Ma, B L Lopez, G L Liu, et al.
Cardiovascular Research|May 30, 2001
Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone ratsF C Barone, R W Coatney, S Chandra, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995
Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damageX Wang, T L Yue, F C Barone, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2010
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumorsF Caponigro, D Lorusso, G Fornari, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Acute stroke therapy: translating preclinical neuroprotection to therapeutic realityA A Parsons, E A Irving, J J Legos, et al.
Experimental Neurology|May 9, 2008
SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protectionJeffrey J Legos, Stephen C Lenhard, Robin E Haimbach, et al.
Stroke|September 1, 1992
Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemiaF C Barone, D B Schmidt, L M Hillegass, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertensionChristian T Abrahamsen, Frank C Barone, Wallace G Campbell, et al.
Scientific Reports|May 4, 2023
The SciQA Scientific Question Answering Benchmark for Scholarly KnowledgeSören Auer, Dante A C Barone, Cassiano Bartz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2014
A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancerM Aglietta, C Barone, M B Sawyer, et al.
Pageof 40

Showing results (351-360 of 399) with videos related to

Sort By:
Pageof 40
Circulation Research|June 1, 1997
Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injuryX L Ma, B L Lopez, G L Liu, et al.
Cardiovascular Research|May 30, 2001
Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone ratsF C Barone, R W Coatney, S Chandra, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995
Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damageX Wang, T L Yue, F C Barone, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2010
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumorsF Caponigro, D Lorusso, G Fornari, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Acute stroke therapy: translating preclinical neuroprotection to therapeutic realityA A Parsons, E A Irving, J J Legos, et al.
Experimental Neurology|May 9, 2008
SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protectionJeffrey J Legos, Stephen C Lenhard, Robin E Haimbach, et al.
Stroke|September 1, 1992
Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemiaF C Barone, D B Schmidt, L M Hillegass, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertensionChristian T Abrahamsen, Frank C Barone, Wallace G Campbell, et al.
Scientific Reports|May 4, 2023
The SciQA Scientific Question Answering Benchmark for Scholarly KnowledgeSören Auer, Dante A C Barone, Cassiano Bartz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2014
A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancerM Aglietta, C Barone, M B Sawyer, et al.
Pageof 40